Abbott Laboratories SEC filings ABT

Abbott Laboratories has 1,001 filings in SEC EDGAR's recent list, going back to Jul 12, 2018. Its latest annual report, Form ARS, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (other events). The company's fiscal year ends on December 31.

Abbott Laboratories SEC filings
Form Description Filed Period
8-K Current report
Other events
Oct 21, 2026 Oct 21, 2026
8-K Current report
Results of operations
Oct 21, 2026 Oct 21, 2026
8-K Current report
Regulation FD disclosure, Other events
Aug 20, 2026 Aug 20, 2026
8-K Current report
Results of operations
Jul 16, 2026 Jul 16, 2026
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
Apr 27, 2026 Apr 24, 2026
8-K Current report
Other events
Apr 17, 2026 Apr 10, 2026
8-K Current report
Results of operations
Apr 16, 2026 Apr 16, 2026
8-K Current report
Other events
Mar 23, 2026 Mar 23, 2026
8-K Current report
Material agreement, New debt
Mar 9, 2026 Mar 9, 2026
8-K Current report
Material agreement
Feb 26, 2026 Feb 23, 2026
8-K Current report
Bylaw or fiscal year change
Feb 20, 2026 Feb 20, 2026
8-K Current report
Results of operations
Jan 22, 2026 Jan 22, 2026
8-K Current report
Officer or director change, Bylaw or fiscal year change
Dec 12, 2025 Dec 12, 2025
8-K Current report Nov 21, 2025 Nov 18, 2025
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Nov 20, 2025 Nov 19, 2025
8-K Current report
Results of operations
Oct 15, 2025 Oct 15, 2025
8-K Current report
Results of operations
Jul 17, 2025 Jul 17, 2025
8-K Current report
Officer or director change
May 1, 2025 Apr 25, 2025
8-K Current report
Shareholder vote results
Apr 28, 2025 Apr 25, 2025
8-K Current report
Results of operations
Apr 16, 2025 Apr 16, 2025
8-K Current report
Results of operations
Jan 22, 2025 Jan 22, 2025
8-K Current report
Officer or director change
Nov 15, 2024 Nov 12, 2024
8-K Current report
Results of operations
Oct 16, 2024 Oct 16, 2024
8-K Current report
Results of operations
Jul 18, 2024 Jul 18, 2024
8-K Current report
Officer or director change
May 1, 2024 Apr 26, 2024
8-K Current report
Shareholder vote results
Apr 29, 2024 Apr 26, 2024
8-K Current report
Results of operations
Apr 17, 2024 Apr 17, 2024
8-K Current report
Material agreement, Agreement ended, New debt
Jan 29, 2024 Jan 29, 2024
8-K Current report
Results of operations
Jan 24, 2024 Jan 24, 2024
8-K Current report
Results of operations
Oct 18, 2023 Oct 18, 2023
8-K/A Amended current report
Shareholder vote results
Sep 1, 2023 Apr 28, 2023
8-K Current report
Results of operations
Jul 20, 2023 Jul 20, 2023
8-K Current report
Officer or director change
Jun 12, 2023 Jun 9, 2023
8-K/A Amended current report
Shareholder vote results
Jun 9, 2023 Apr 28, 2023
8-K Current report
Shareholder vote results
May 2, 2023 Apr 28, 2023
8-K Current report
Results of operations
Apr 19, 2023 Apr 19, 2023
8-K Current report
Bylaw or fiscal year change
Feb 17, 2023 Feb 17, 2023
8-K Current report
Results of operations
Jan 25, 2023 Jan 25, 2023
8-K Current report
Bylaw or fiscal year change
Dec 9, 2022 Dec 9, 2022
8-K Current report
Officer or director change
Oct 21, 2022 Oct 18, 2022
8-K Current report
Results of operations
Oct 19, 2022 Oct 19, 2022
8-K Current report
Officer or director change, Bylaw or fiscal year change
Sep 15, 2022 Sep 15, 2022
8-K Current report
Results of operations
Jul 20, 2022 Jul 20, 2022
8-K Current report
Shareholder vote results
May 2, 2022 Apr 29, 2022
8-K Current report
Results of operations
Apr 20, 2022 Apr 20, 2022
8-K Current report
Bylaw or fiscal year change
Feb 22, 2022 Feb 18, 2022
8-K Current report
Regulation FD disclosure
Feb 18, 2022 Feb 18, 2022
8-K Current report
Results of operations
Jan 26, 2022 Jan 26, 2022
8-K Current report
Officer or director change
Dec 13, 2021 Dec 9, 2021
8-K Current report
Officer or director change, Bylaw or fiscal year change
Dec 10, 2021 Dec 9, 2021
8-K Current report
Results of operations
Oct 20, 2021 Oct 20, 2021
8-K Current report
Officer or director change, Bylaw or fiscal year change
Sep 1, 2021 Aug 30, 2021
8-K Current report
Results of operations
Jul 22, 2021 Jul 22, 2021
8-K Current report
Exit or restructuring costs, Regulation FD disclosure
Jun 3, 2021 May 27, 2021
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
Apr 26, 2021 Apr 23, 2021
8-K Current report
Results of operations
Apr 20, 2021 Apr 20, 2021
8-K Current report
Officer or director change, Bylaw or fiscal year change
Feb 19, 2021 Feb 18, 2021
8-K Current report
Results of operations
Jan 27, 2021 Jan 27, 2021
8-K Current report
Officer or director change
Nov 20, 2020 Nov 20, 2020
8-K Current report
Material agreement, Agreement ended, New debt
Nov 12, 2020 Nov 12, 2020
8-K Current report
Results of operations
Oct 21, 2020 Oct 21, 2020
8-K Current report
Results of operations
Jul 16, 2020 Jul 16, 2020
8-K Current report
Material agreement, New debt
Jun 24, 2020 Jun 22, 2020
8-K Current report
Shareholder vote results
Apr 28, 2020 Apr 24, 2020
8-K Current report
Results of operations
Apr 16, 2020 Apr 16, 2020
8-K Current report
Officer or director change, Bylaw or fiscal year change
Feb 27, 2020 Feb 21, 2020
8-K Current report
Officer or director change
Feb 11, 2020 Feb 7, 2020
8-K Current report
Results of operations
Jan 22, 2020 Jan 22, 2020
8-K Current report
Officer or director change
Jan 8, 2020 Jan 3, 2020
8-K Current report
Agreement ended, Other events
Dec 19, 2019 Dec 19, 2019
8-K Current report
Other events
Nov 19, 2019 Nov 19, 2019
8-K Current report
Officer or director change, Bylaw or fiscal year change
Nov 13, 2019 Nov 12, 2019
8-K Current report
Other events
Nov 12, 2019 Nov 12, 2019
8-K Current report
Results of operations
Oct 16, 2019 Oct 16, 2019
8-K Current report
Other events
Oct 15, 2019 Oct 11, 2019
8-K Current report
Officer or director change, Bylaw or fiscal year change
Sep 10, 2019 Sep 9, 2019
8-K Current report
Results of operations
Jul 17, 2019 Jul 17, 2019
8-K Current report
Officer or director change
Jun 25, 2019 Jun 20, 2019
8-K Current report
Shareholder vote results
Apr 30, 2019 Apr 26, 2019
8-K Current report
Results of operations
Apr 17, 2019 Apr 17, 2019
8-K Current report
Agreement ended, Other events
Feb 25, 2019 Feb 24, 2019
8-K Current report
Results of operations
Jan 23, 2019 Jan 23, 2019
8-K Current report
Material agreement, Agreement ended, New debt
Nov 30, 2018 Nov 30, 2018
8-K Current report
Officer or director change
Nov 14, 2018 Nov 14, 2018
8-K Current report
Agreement ended, Other events
Oct 29, 2018 Oct 28, 2018
8-K Current report
Results of operations
Oct 17, 2018 Oct 17, 2018
8-K Current report
Officer or director change
Oct 15, 2018 Oct 11, 2018
8-K Current report
Material agreement, Agreement ended, New debt, Other events
Sep 28, 2018 Sep 27, 2018
8-K Current report
Regulation FD disclosure
Sep 19, 2018 Sep 18, 2018
8-K Current report
Results of operations
Jul 18, 2018 Jul 18, 2018

Showing 90 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ABT (NYSE)
Fiscal year ends
December 31
Incorporated in
IL
Headquarters
Abbott Park, IL
SEC filer status
Large accelerated filer
SEC CIK
1800

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.